Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.
about
Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription.Diverse roles of LPA signaling in the intestinal epithelium.Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.Altered gene and protein expression by Nm23-H1 in metastasis suppression.Sphingosine kinase 1 is upregulated with lysophosphatidic acid receptor 2 in human colorectal cancer.Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells.Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.Clinical-translational approaches to the Nm23-H1 metastasis suppressor.ERBBs in the gastrointestinal tract: recent progress and new perspectives.Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells.Type 2 lysophosphatidic acid receptor in gastric surface mucous cells: Possible implication of prostaglandin E2 production.Hedgehog-glioma-associated oncogene homolog-1 signaling in colon cancer cells and its role in the celecoxib-mediated anti-cancer effect.Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer.
P2860
Q34165938-84D6CFB3-211B-4D8F-8C2A-66C30D5BF82DQ35533312-68474D2F-D5C4-4140-BB01-9CF3AE156199Q36291482-EE3541E9-34AE-4C24-96FD-0D9342274135Q36445269-302F0C8D-C266-4286-88D7-F8E27EC250AFQ36621483-B4CB3BCF-97BD-4E00-B18C-8EC34AC567AFQ36804966-412C5599-A56A-49E4-BCA6-382BA44CB16FQ37137675-8C687885-622D-4CCD-A813-6A2933433732Q37138876-60DA528F-EC7A-4A64-852C-ABADD90D9126Q37139302-B25595AC-4F01-4E7C-8FA7-EE95A277E059Q37185003-65058044-0E61-497F-B9CF-00FE41B24FADQ37242266-FDAC99D4-0303-4E04-B5CC-E2DADEDFB13BQ37337542-9DCF6C18-3A3F-437C-B124-D4FC0F723D54Q37391105-42F11FE0-577F-4407-B14F-122D0DFE4C1AQ38817086-B9CE53C2-1442-4807-8ABE-3C6B90D42934Q39038640-99774E14-7A6F-4617-AE91-B92D24A1AB46Q42931072-9270C628-23F8-4D6E-824C-60119936AE00Q46420172-5115B29E-00D6-4C1C-BADB-46465D3207AA
P2860
Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Lysophosphatidic acid transact ...... human colon cancer LoVo cells.
@en
type
label
Lysophosphatidic acid transact ...... human colon cancer LoVo cells.
@en
prefLabel
Lysophosphatidic acid transact ...... human colon cancer LoVo cells.
@en
P2093
P2860
P356
P1476
Lysophosphatidic acid transact ...... human colon cancer LoVo cells.
@en
P2093
Hirokazu Nagawa
Hironori Yamaguchi
Joji Kitayama
Toshiaki Watanabe
P2860
P304
P356
10.3748/WJG.V11.I36.5638
P407
P577
2005-09-01T00:00:00Z